Great news! The NIH has awarded five years of funding to renew the Brittle Bone Disorders Consortium (BBDC)! This critical funding allows researchers, clinicians, and the OI Foundation to continue working together to improve understanding and care for people with osteogenesis imperfecta (OI). This is the third and final cycle of this important program.

“The Osteogenesis Imperfecta Foundation and the OI patient community are grateful for the opportunity to continue collaborating with rare bone disease experts as we work together to accelerate research that will improve the quality of life of people living with OI” – OIF CEO Tracy Hart

Read more: https://www.bcm.edu/news/nih-awards-more-than-15-million-to-fund-two-rare-diseases-consortia